M. Franco G. Salvoza

Array ( [id] => 12466326 [patent_doc_number] => 09987350 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-06-05 [patent_title] => Antigens and vaccines directed against human enteroviruses [patent_app_type] => utility [patent_app_number] => 14/402495 [patent_app_country] => US [patent_app_date] => 2012-11-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 25 [patent_no_of_words] => 17732 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 56 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14402495 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 15818831 [patent_doc_number] => 10634589 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-04-28 [patent_title] => Methods of reducing or eliminating protein modification and degradation arising from exposure to UV light [patent_app_type] => utility [patent_app_number] => 14/353704 [patent_app_country] => US [patent_app_date] => 2012-10-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 20205 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 168 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14353704 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11319565 [patent_doc_number] => 09518303 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-12-13 [patent_title] => 'Methods and compositions for identifying enterovirus' [patent_app_type] => utility [patent_app_number] => 14/353832 [patent_app_country] => US [patent_app_date] => 2012-10-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 4 [patent_no_of_words] => 7644 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 58 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14353832 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10938929 [patent_doc_number] => 20140341949 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-11-20 [patent_title] => 'VACCINE' [patent_app_type] => utility [patent_app_number] => 14/349539 [patent_app_country] => US [patent_app_date] => 2012-10-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 10351 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14349539 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11922901 [patent_doc_number] => 09790472 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-10-17 [patent_title] => 'Method of detecting and/or identifying adeno-associated virus (AAV) sequences and isolating novel sequences identified thereby' [patent_app_type] => utility [patent_app_number] => 13/633971 [patent_app_country] => US [patent_app_date] => 2012-10-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 112 [patent_figures_cnt] => 112 [patent_no_of_words] => 31955 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 96 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13633971 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11250370 [patent_doc_number] => 09475861 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-10-25 [patent_title] => 'Binding molecule having influenza A virus-neutralizing activity produced from human B cell' [patent_app_type] => utility [patent_app_number] => 14/348284 [patent_app_country] => US [patent_app_date] => 2012-09-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 12420 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 399 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14348284 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8767094 [patent_doc_number] => 20130095131 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-04-18 [patent_title] => 'Vaccine and Therapeutic Delivery System' [patent_app_type] => utility [patent_app_number] => 13/624146 [patent_app_country] => US [patent_app_date] => 2012-09-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 35 [patent_figures_cnt] => 35 [patent_no_of_words] => 14650 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13624146 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10225829 [patent_doc_number] => 20150110823 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-04-23 [patent_title] => 'PARTICULATE VACCINE FORMULATIONS' [patent_app_type] => utility [patent_app_number] => 14/344327 [patent_app_country] => US [patent_app_date] => 2012-09-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 11111 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14344327 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8767521 [patent_doc_number] => 20130095558 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-04-18 [patent_title] => 'PROCESS FOR PRODUCING RECOMBINANT HUMAN ENDOSTATIN ADENOVIRUS' [patent_app_type] => utility [patent_app_number] => 13/549607 [patent_app_country] => US [patent_app_date] => 2012-07-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 6198 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13549607 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9477236 [patent_doc_number] => 20140134699 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-05-15 [patent_title] => 'NOVEL STABILISATION METHOD FOR VIRUSES OR BACTERIA' [patent_app_type] => utility [patent_app_number] => 14/129057 [patent_app_country] => US [patent_app_date] => 2012-06-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 11521 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14129057 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9641807 [patent_doc_number] => 20140219918 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-08-07 [patent_title] => 'PEPTIDE' [patent_app_type] => utility [patent_app_number] => 14/129613 [patent_app_country] => US [patent_app_date] => 2012-06-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 12478 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14129613 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10628730 [patent_doc_number] => 09346874 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-05-24 [patent_title] => 'Binding members for human cytomegalovirus' [patent_app_type] => utility [patent_app_number] => 13/530891 [patent_app_country] => US [patent_app_date] => 2012-06-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 18 [patent_no_of_words] => 50524 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13530891 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9396121 [patent_doc_number] => 20140093527 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-04-03 [patent_title] => 'COMPOSITIONS AND METHODS FOR GLIOBLASTOMA TREATMENT' [patent_app_type] => utility [patent_app_number] => 14/123057 [patent_app_country] => US [patent_app_date] => 2012-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 17464 [patent_no_of_claims] => 46 [patent_no_of_ind_claims] => 30 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14123057 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8441521 [patent_doc_number] => 20120258137 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-10-11 [patent_title] => 'IMMUNOGENIC COMPOSITIONS COMPRISING NANOEMULSION AND HEPATITIS B VIRUS IMMUNOGEN AND METHODS OF USING THE SAME' [patent_app_type] => utility [patent_app_number] => 13/487925 [patent_app_country] => US [patent_app_date] => 2012-06-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 45253 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13487925 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12016947 [patent_doc_number] => 09809639 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-11-07 [patent_title] => 'Purification of biological products by constrained cohydration chromatography' [patent_app_type] => utility [patent_app_number] => 14/124706 [patent_app_country] => US [patent_app_date] => 2012-06-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 19723 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14124706 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8659540 [patent_doc_number] => 20130040370 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-02-14 [patent_title] => 'Novel Method for Vacuum-Assisted Preservation of Biologics Including Vaccines' [patent_app_type] => utility [patent_app_number] => 13/485437 [patent_app_country] => US [patent_app_date] => 2012-05-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 19286 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13485437 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9383471 [patent_doc_number] => 20140086952 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-03-27 [patent_title] => 'Vaccine Adjuvants from Self-Assembling Peptides' [patent_app_type] => utility [patent_app_number] => 14/118700 [patent_app_country] => US [patent_app_date] => 2012-05-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 42 [patent_figures_cnt] => 42 [patent_no_of_words] => 11121 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14118700 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8381441 [patent_doc_number] => 20120225067 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-09-06 [patent_title] => 'Composition and Method for Mediating an Immune Response' [patent_app_type] => utility [patent_app_number] => 13/470227 [patent_app_country] => US [patent_app_date] => 2012-05-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 15859 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13470227 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9517796 [patent_doc_number] => 20140154288 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-06-05 [patent_title] => 'PAPAYA MOSAIC VIRUS COMPOSITIONS AND USES THEREOF FOR STIMULATION OF THE INNATE IMMUNE RESPONSE' [patent_app_type] => utility [patent_app_number] => 14/117363 [patent_app_country] => US [patent_app_date] => 2012-05-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 33 [patent_figures_cnt] => 33 [patent_no_of_words] => 19916 [patent_no_of_claims] => 69 [patent_no_of_ind_claims] => 35 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14117363 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9685349 [patent_doc_number] => 20140242113 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-08-28 [patent_title] => 'LIQUID VACCINE PREPARATIONS' [patent_app_type] => utility [patent_app_number] => 14/114698 [patent_app_country] => US [patent_app_date] => 2012-04-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11345 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14114698 [rel_patent_id] =>[rel_patent_doc_number] =>)